Skip to main content
Equibles
GRDN logo

GRDN · Guardian Pharmacy Services, Inc.

Track GRDN — free

Use GRDN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about GRDN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$38.43 -0.03 (-0.08%) At close · Aug 14
Market Cap
$2.43B
Shares
63.34M

Guardian Pharmacy Services, Inc. Earnings Call Transcripts

Every quarterly earnings call for Guardian Pharmacy Services, Inc. (GRDN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲19.7% $314.39M −$121.99M '24 Q3 24-11-12 · $338.57M $4.85M '24 Q4 25-03-26 ▲19.6% $329.31M $9.45M '25 Q1 25-05-12 ▲14.8% $344.33M $9.03M '25 Q2 25-08-11 ▲20% $377.43M $9.82M '25 Q3 25-11-10 ▲17.4% $397.62M $20.92M '25 Q4 26-03-11 ▲2.2% $336.60M $13.29M '26 Q1 26-05-06 LATEST ▲2.2% $351.77M $21.87M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
Guardian Pharmacy Services Second Quarter 2026 Earnings Call
Revenue
$351.77M
▲ 2.2% YoY
Gross margin
22.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Guardian Pharmacy Services, Inc. Q1 FY2026 Earnings Call
Positive tone IRA transition and drug pricing impact Gross profit and EBITDA results M&A pipeline and national accounts
Revenue
$336.60M
▲ 2.2% YoY
Gross margin
22.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-11
Guardian Pharmacy Services, Inc. Q4 FY2025 Earnings Call
Confident tone Inflation Reduction Act (IRA) Impact Vaccine Clinics Clinical Value and Interventions
Revenue
$397.62M*
▲ 17.4% YoY
Gross margin
21.5%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-10
Guardian Pharmacy Services, Inc. Q3 FY2025 Earnings Call
Positive tone Acquisitions and Greenfields Margin Pressure from New Pharmacies Revenue and EBITDA Growth
Revenue
$377.43M
▲ 20% YoY
Gross margin
19.8%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Guardian Pharmacy Services, Inc. Q2 FY2025 Earnings Call
Revenue
$344.33M
▲ 14.8% YoY
Gross margin
19.8%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Guardian Pharmacy Services, Inc. Q1 FY2025 Earnings Call
Revenue
$329.31M
▲ 19.6% YoY
Gross margin
19.5%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-26
Guardian Pharmacy Services, Inc. Q4 FY2024 Earnings Call
Confident tone Revenue and EBITDA growth M&A and greenfield expansion Inflation Reduction Act risk
Revenue
$338.57M*
Gross margin
19.8%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Guardian Pharmacy Services, Inc. Q3 FY2024 Earnings Call
Revenue
$314.39M
▲ 19.7% YoY
Gross margin
19.4%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–8 of 8 earnings calls
Key facts CIK 1802255 CUSIP 40145W101 13F (30d) 176 filings 176 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)